Skip to main content
    E

    Ensysce Biosciences Inc (ENSC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.42
    +0.03 (+8.06%)

    Market Cap: $8.14M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Ensysce Biosciences Inc (ENSC) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Ensysce Biosciences (ENSC) trades at 1.2x sales and 0.3x book value. Its forward P/E is 0.9x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E0.9x
    Price to sales1.2x
    Price to book0.3x
    PEGN/A
    As of Nov 17, 2026

    Valuation History

    Year endPriceP/EP/SP/B
    2025$0.92N/A0.5x7.3x
    2024$8.14N/AN/A2.7x
    2023$15.89N/A0.9xN/A
    2022$134.99N/AN/AN/A
    2021$16,918.31N/AN/AN/A
    2020$44,760.45N/AN/AN/A
    2019$37,508.26154.5xN/AN/A
    2018$35,348.47N/AN/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    Frequently Asked Questions About ENSC

    What is ENSC's forward P/E ratio?

    Ensysce Biosciences has a forward P/E ratio of 0.9x.

    What is ENSC's price to sales ratio?

    Ensysce Biosciences has a price to sales ratio of 1.2x.